Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DARIFENACIN for Urinary incontinence: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where DARIFENACIN was used for Urinary incontinence.

Most Reported Side Effects for DARIFENACIN

Side Effect Reports % Deaths Hosp.
Asphyxia 20 24.1% 20 0
Arteriosclerosis coronary artery 16 19.3% 16 0
Death 11 13.3% 11 0
Drug ineffective 11 13.3% 0 2
Drug interaction 11 13.3% 0 8
Peripheral swelling 8 9.6% 0 7
Acute kidney injury 7 8.4% 0 5
Hyponatraemia 7 8.4% 0 7
Urinary retention 7 8.4% 0 6
Weight decreased 7 8.4% 0 4
Arteriosclerosis 6 7.2% 6 0
Cognitive disorder 6 7.2% 0 6
Concomitant disease aggravated 6 7.2% 0 6
Dry mouth 6 7.2% 0 3
Dysuria 6 7.2% 0 6

Other Indications for DARIFENACIN

Product used for unknown indication (35) Micturition urgency (9) Hypertonic bladder (7) Dysuria (6) Lower urinary tract symptoms (6) Urinary retention (6) Urinary tract infection (6)

Other Drugs Used for Urinary incontinence

MIRABEGRON (1,081) SOLIFENACIN (777) OXYBUTYNIN (581) FESOTERODINE (398) OXYTROL FOR WOMEN (265) TOLTERODINE (250) VIBEGRON (213) TROSPIUM (112) ESTRADIOL (89) TAMSULOSIN (78)

Related Pages

DARIFENACIN Full Profile All Urinary incontinence Drugs DARIFENACIN Demographics DARIFENACIN Timeline